Levodopa and pramipexole combination therapy efficacy in Vietnamese patients with Parkinson’s disease: a randomized controlled trial

Levodopa and pramipexole combination therapy efficacy in Vietnamese patients with Parkinson’s disease: a randomized controlled trial

Early diagnosis and appropriate treatment of Parkinson's disease to minimize the adverse effects of the disease and drug side effects on the patient. Using levodopa combined with pramipexole is an effective therapy for treating Parkinson's disease. Objectives — This study aims to evaluate...

Full description

Saved in:

Bibliographic Details
Main Authors:	Minh Van Le, Dat Tien Diep, Tam Thai Thanh Tran, Tho Kieu Anh Pham, Bao Lam Thai Tran, Thang Nguyen
Format:	Article
Language:	English
Published:	Limited liability company «Science and Innovations» (Saratov) 2024-03-01
Series:	Russian Open Medical Journal
Subjects:	parkinson's disease levodopa pramipexole the unified parkinson's disease rating the parkinson's disease questionnaire randomized controlled clinical trial
Online Access:	https://romj.org/node/552
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USE OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY-STAGE PARKINSON’S DISEASE: DESCRIPTION OF A CLINICAL CASE
by: N. V. Fedorova, et al.
Published: (2014-11-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Hyponatremia in Parkinson’s Disease: The Impact of Carbidopa-Levodopa Therapy
by: Elizabeth Schumacher, et al.
Published: (2025-06-01)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

Contribution of dopaminergic polymorphisms to levodopa treatment response and drug concentration in Chinese patients with Parkinson’s disease
by: Xiaoqin He, et al.
Published: (2025-01-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
by: Sebastiano Gangemi, et al.
Published: (2003-01-01)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)

Pain in Parkinson's disease Dor na doença de Parkinson
by: Grace Helena Letro, et al.
Published: (2009-09-01)

Levodopa-induced motor complications associated with benserazide and carbidopa in Parkinson’s disease: a disproportionality analysis of the FAERS database
by: Huaide Qiu, et al.
Published: (2025-03-01)

How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01)

Efficacy and motor complications of original and generic levodopa in Parkinson&#39;s disease treatment
by: Kasemsap N, et al.
Published: (2016-05-01)

Working memory in Parkinson's disease patients: clinical features and response to levodopa Memória de trabalho em pacientes com doença de Parkinson: características clínicas e resposta a levodopa
by: Rogério Beato, et al.
Published: (2008-06-01)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

Translational profiling reveals novel gene expression changes in the direct and indirect pathways in a mouse model of levodopa induced dyskinesia
by: Sabika Jafri, et al.
Published: (2025-03-01)

How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson’s disease
by: Robert A. Hauser, et al.
Published: (2025-01-01)

Levodopa induces thyroid function regulation in a patient with thyroid hormone resistance and Parkinson’s disease: a case report
by: Gabriela Rozo-Paz, et al.
Published: (2025-03-01)

Inefficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson’s Disease Patients with Levodopa-Induced Dyskinesias: Results from a Pilot Study
by: Alma Medrano-Hernández, et al.
Published: (2025-07-01)

PE-005 Perfil farmacoepidemiológico dos pacientes com Doença de Parkinson atendidos no CEAF de Maceió
by: Danielle Bezerra de Santana
Published: (2025-03-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease
by: Isabella Araújo Mota, et al.

Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s
by: Bruno Lopes dos Santos-Lobato, et al.
Published: (2016-08-01)

Inhibition of levodopa metabolism to dopamine by honokiol short-chain fatty acid derivatives may enhance therapeutic efficacy in Parkinson’s disease
by: Gang Cheng, et al.
Published: (2025-06-01)

Executive dysfunctions impair and levodopa improves articulatory timing in Parkinson‘s disease
by: Elisa Herbig, et al.
Published: (2025-07-01)

Dementia with Lewy bodies
by: O. S. Levin, et al.
Published: (2018-11-01)

Identification of electromyographic patterns of bradykinesia in patients with Parkinson's disease
by: Nikita Kozulin, et al.
Published: (2024-10-01)

Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis
by: Rong Tang, et al.
Published: (2025-05-01)

Symptom improvement in a South Asian patient with Parkinson’s disease treated with immediate- and extended-release carbidopa–levodopa: a case report
by: Gail Reiner, et al.
Published: (2025-07-01)

Drug utilization study of antiparkinsonian medication in Romania during 25 years
by: Camelia Bucsa, et al.
Published: (2025-02-01)

Investigating white matter alterations in Parkinson’s disease using multi-shell free-water DTI and NODDI: insights into neurodegeneration and levodopa effects
by: Maurizio Bergamino, et al.
Published: (2025-07-01)

A comprehensive review of deep brain stimulation for Parkinson's disease: The history, current state of the art and future possibilities
by: Avery Foote, et al.
Published: (2025-06-01)

Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster
by: Herbert Izo, Ninsiima, et al.
Published: (2020)

A case of Frégoli syndrome following 24-hour levodopa-carbidopa intestinal gel infusion in a patient with Parkinson’s disease undergoing STN-DBS
by: Shunsuke Ogata, et al.
Published: (2025-01-01)

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
by: Bruno Lopes Santos-Lobato, et al.
Published: (2023-05-01)

Parkinsonian central pain is linked to the connectivity of the nucleus accumbens and the anterior insula
by: Karel Joineau, et al.
Published: (2024-03-01)

STUDY OF RAPITALAM INFLUENCE ON OXOTREMORINE-INDUCED TREMOR
by: N. V. Avdeeva
Published: (2019-05-01)

Bioequivalence of Foslevodopa/Foscarbidopa continuous subcutaneous infusion to arm, thigh, or flank versus abdomen in healthy and advanced Parkinson’s disease individuals
by: Yi Rang Han, et al.
Published: (2025-01-01)

Persistence and adherence to levodopa adjunct medications in elderly patients with Parkinson’s disease: a retrospective cohort study using a Japanese claims database
by: Masahiro Nagai, et al.
Published: (2025-04-01)

Wearable multimodal sensing for quantifying the cardiovascular autonomic effects of levodopa in parkinsonism
by: John A. Berkebile, et al.
Published: (2025-04-01)

Characterizing Secondary and Atypical Parkinsonisms: Defining Features and Clinical Variability
by: Iraís Viveros-Martínez, et al.
Published: (2024-11-01)